Top Markets
Coin of the day
DNA Chip Research Inc. DNA Chip Research Inc.

DNA Chip Research Inc.

2397
Rank in Stocks #25566
Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the... Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the creation of DNA microarrays. Its operations encompass research and development, bespoke contract research, and comprehensive diagnostic assistance. A notable product is the Tbone EX Kit, supplied to forensic laboratories across Japan, including those within law enforcement agencies and academic institutions. Furthermore, the company is behind the development of the EGFR (epidermal growth factor receptor) Liquid gene analysis software, a diagnostic tool designed to identify mutations in the EGFR-encoding gene from DNA harvested from plasma or cancerous tissues. This software also assesses the effectiveness of EGFR tyrosine kinase inhibitors for individuals suffering from non-small cell lung cancer. Beyond this, they are actively engaged in creating a comprehensive gene panel for cancer screening through advanced sequencing technologies. Established in 1999, the firm operates out of Tokyo, Japan.
Share Price
$7.12
Last synced: 2025-06-18
Market Cap
$48.17M
Change (1 day)
-5.48%
Change (1 year)
0.00%
Country
JP
Trade DNA Chip Research Inc. (2397)

Category

Revenue for DNA Chip Research Inc. (2397)
Revenue in Aug 2026 TTM: 0
According to DNA Chip Research Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DNA Chip Research Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$7.23B -
US